M E. Jones, et.al., Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity., Proceedings of the National Academy of Sciences of the United States of America, 2000, 97

http://rdf.ncbi.nlm.nih.gov/pubmed/11070087

M E. Jones, et.al., Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity., Proceedings of the National Academy of Sciences of the United States of America, 2000, 97

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating insulin level_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0002079I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased total body fat amount_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0010024I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• bradykinesia_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0005156I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased fat cell size_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0006094I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased renal fat pad weight_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0009302I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased circulating triglyceride level_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0001552I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• abnormal glucose homeostasis_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0002078I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• pale liver_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0000603I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased circulating leptin level_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0005669I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased circulating cholesterol level_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0005178I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• enlarged liver_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0000599I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased circulating HDL cholesterol level_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0001556I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased gonadal fat pad weight_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0009285I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• increased body weight_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0001260I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• hepatic steatosis_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0002628I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi
• decreased lean body mass_Cyp19a1<tm1Esi>/Cyp19a1<tm1Esi>
  http://metadb.riken.jp/0003961I129S6SvEvTacCyp19a1tm1EsiCyp19a1tm1EsiCyp19a1tm1Esi